These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8755840)

  • 61. Changes in liver enzymes after surgery in anti-hepatitis C virus-positive patients.
    Murakami S; Okubo K; Tsuji Y; Sakata H; Takahashi T; Kikuchi M; Hirayama R
    World J Surg; 2004 Jul; 28(7):671-4. PubMed ID: 15175902
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatitis C virus infection and oral lichen planus: a report from The Netherlands.
    van der Meij EH; van der Waal I
    J Oral Pathol Med; 2000 Jul; 29(6):255-8. PubMed ID: 10890555
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Liver steatosis and chronic hepatitis C: a spurious association?
    Fiore G; Fera G; Napoli N; Vella F; Schiraldi O
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):125-9. PubMed ID: 8723415
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of liver function tests in scleroderma patients.
    Salem GI; Abdulrahman AA
    Rheumatol Int; 2012 Aug; 32(8):2371-5. PubMed ID: 21644046
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum.
    Dalgard O; Jeansson S; Skaug K; Raknerud N; Bell H
    Scand J Gastroenterol; 2003 Aug; 38(8):864-70. PubMed ID: 12940441
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatitis C virus infection in 'primary' Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients.
    García-Carrasco M; Ramos M; Cervera R; Font J; Vidal J; Muñoz FJ; Miret C; Espinosa G; Ingelmo M
    Ann Rheum Dis; 1997 Mar; 56(3):173-5. PubMed ID: 9135219
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence of hepatitis C virus infection in patients with rheumatoid arthritis.
    Maillefert JF; Muller G; Falgarone G; Bour JB; Ratovohery D; Dougados M; Tavernier C; Breban M
    Ann Rheum Dis; 2002 Jul; 61(7):635-7. PubMed ID: 12079907
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Frequency of antibodies against the hepatitis C virus in patients with hepatic cirrhosis in Yucatan, Mexico.
    Góngora-Biachi RA; Castro-Sansores CJ; González-Martínez P; Lara-Perera DM; Garrido-Palma J; Lara-Perera V
    Salud Publica Mex; 2003; 45(5):346-50. PubMed ID: 14628613
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Matched population-based study examining the risk of type 2 diabetes in people with and without diagnosed hepatitis C virus infection.
    Schnier C; Wild S; Kurdi Z; Povey C; Goldberg DJ; Hutchinson SJ
    J Viral Hepat; 2016 Aug; 23(8):596-605. PubMed ID: 26910297
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C.
    Minola E; Prati D; Suter F; Maggiolo F; Caprioli F; Sonzogni A; Fraquelli M; Paggi S; Conte D
    Blood; 2002 Jun; 99(12):4588-91. PubMed ID: 12036892
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of gamma-glutamyl transferase activity in patients with chronic hepatitis C virus infection.
    Silva IS; Ferraz ML; Perez RM; Lanzoni VP; Figueiredo VM; Silva AE
    J Gastroenterol Hepatol; 2004 Mar; 19(3):314-8. PubMed ID: 14748879
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Severe chronic active hepatitis (autoimmune type) mimicked by coinfection of hepatitis C and human immunodeficiency viruses.
    Berk L; Schalm SW; Heijtink RA
    Gut; 1991 Oct; 32(10):1198-200. PubMed ID: 1955176
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Strategies of hepatitis C screening in general practice. Results of a two-center randomized trial].
    Roudot-Thoraval F; Monnet E; Mercet P; Bastie A; Dhumeaux D; Miguet JP
    Gastroenterol Clin Biol; 2000 Nov; 24(11):1037-41. PubMed ID: 11139672
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of anti-HCV positive blood donors identified during routine screening.
    Esteban JI; Lopez-Talavera JC; Genescà J; Gonzalez A; Vargas V; Buti M; Guardia J; Esteban R
    Arch Virol Suppl; 1992; 4():244-6. PubMed ID: 1450694
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The significance of infection pathways for hepatitis C virus associated chronic liver disease].
    Neumayr G; Judmaier G; Stöffler G; Dietze O; Vogel W
    Z Gastroenterol; 1994 Jun; 32(6):338-41. PubMed ID: 7975763
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HCV infection in HIV-infected individuals.
    Eyigun C; Colantoni A; Van Thiel DH
    J Hepatol; 1997 Nov; 27(5):953-4. PubMed ID: 9382990
    [No Abstract]   [Full Text] [Related]  

  • 77. Labour force participation among individuals with hepatitis C in the US.
    Jacobs P; Ng YC; Stafinski T; Dodd R; Larke B; Wong W
    Pharmacoeconomics; 2003; 21(8):565-72. PubMed ID: 12751914
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical features of patients with type 2 diabetes mellitus and hepatitis C infection.
    Greca LF; Pinto LC; Rados DR; Canani LH; Gross JL
    Braz J Med Biol Res; 2012 Mar; 45(3):284-90. PubMed ID: 22286533
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Liver gamma-glutamyltransferase activity in viral liver disease.
    Itoh S; Nakajima M
    Digestion; 1986; 33(3):121-5. PubMed ID: 2868954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prospective assessment of incidence of fulminant hepatitis in post-transfusion hepatitis: a study of 504 cases.
    Takano S; Omata M; Ohto M; Satomura Y
    Dig Dis Sci; 1994 Jan; 39(1):28-32. PubMed ID: 7506644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.